Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables Across Three Departments within UofL Health
18 Août 2022 - 02:30PM
Milestone Scientific Inc.
(NYSE:MLSS), a leading developer of computerized
drug delivery instruments, that provide painless and precise
injections, today reported that, following a successful evaluation,
it has commenced sales of its CompuFlo® Epidural disposables to
UofL Health (University of Louisville), a leading academic health
system based in Louisville, Kentucky. UofL Health owns and operates
six hospitals and four medical centers, providing patient care to
more than 1.5 million patients each year in the state of Kentucky.
UofL Health has begun implementing the CompuFlo Epidural System for
obstetric anesthesia, acute pain, and chronic pain within its labor
and delivery (L&D), operating room (OR) and pain clinic teams.
Arjan Haverhals, CEO of Milestone Scientific
commented, “We are honored to announce the adoption of the CompuFlo
Epidural System and its CathCheck capability at this leading
academic institution. The instrument is being employed in three
distinct departments: labor & delivery, acute pain and in the
operating room. We are encouraged by this validation as we execute
our strategy to become the new standard of care based on improved
patient outcomes at lower costs.”
The clinical and safety benefits of the CompuFlo
Epidural and CathCheck Verification Systems are backed by
extensive published clinical data demonstrating
significant reductions in epidural punctures, as well as
complication rates, and contribute to a significant savings of time
on the part of anesthesiologists. A recent study has shown
that the CompuFlo Epidural instrument has the potential to
significantly reduce costs associated with morbidity, providing a
direct economic benefit to healthcare institutions.
About UofL Health
UofL Health is a fully integrated regional
academic health system with six hospitals, four medical centers,
Brown Cancer Center, Eye Institute, nearly 200 physician practice
locations, and more than 800 providers in Louisville and the
surrounding counties, including southern Indiana. Additional access
to UofL Health is provided through a partnership with Carroll
County Memorial Hospital. With more than 12,000 team members –
physicians, surgeons, nurses, pharmacists and other highly-skilled
health care professionals, UofL Health is focused on one
mission: to transform the health of communities we serve through
compassionate, innovative, patient-centered care. To learn more,
visit: www.uoflhealth.org.
About Milestone Scientific
Inc.
Milestone Scientific Inc. (MLSS), a technology
focused medical research and development company that patents,
designs and develops innovative injection technologies and
instruments for medical, dental and cosmetic applications.
Milestone Scientific’s computer-controlled systems are designed to
make injections precise, efficient and increase the overall patient
comfort and safety. Their proprietary DPS Dynamic Pressure Sensing
Technology® instruments is the platform to advance the development
of next-generation devices, regulating flow rate and monitoring
pressure from the tip of the needle, through platform extensions of
subcutaneous drug delivery, including local anesthetic. To learn
more, view the MLSS brand video or visit
milestonescientific.com.
Safe Harbor Statement
This press release contains forward-looking
statements regarding the timing and financial impact of Milestone's
ability to implement its business plan, expected revenues, timing
of regulatory approvals and future success. These statements
involve a number of risks and uncertainties and are based on
assumptions involving judgments with respect to future economic,
competitive and market conditions, future business decisions and
regulatory developments, all of which are difficult or impossible
to predict accurately and many of which are beyond Milestone's
control. Some of the important factors that could cause actual
results to differ materially from those indicated by the
forward-looking statements are general economic conditions, failure
to achieve expected revenue growth, changes in our operating
expenses, adverse patent rulings, FDA or legal developments,
competitive pressures, changes in customer and market requirements
and standards, and the risk factors detailed from time to time in
Milestone's periodic filings with the Securities and Exchange
Commission, including without limitation, Milestone's Annual Report
for the year ended December 31, 2021. The forward-looking
statements in this press release are based upon management's
reasonable belief as of the date hereof. Milestone undertakes no
obligation to revise or update publicly any forward-looking
statements for any reason.
Contact: Crescendo Communications, LLCEmail:
mlss@crescendo-ir.comTel: 212-671-1020
Milestone Scientific (AMEX:MLSS)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Milestone Scientific (AMEX:MLSS)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024